Bergamaschi D - Search Results

1

A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo.

Bell HS, Dufes C, O'Prey J, Crighton D, Bergamaschi D, Lu X, Schätzlein AG, Vousden KH, Ryan KM. Bell HS, et al. Among authors: bergamaschi d. J Clin Invest. 2007 Apr;117(4):1008-18. doi: 10.1172/JCI28920. Epub 2007 Mar 8. J Clin Invest. 2007. PMID: 17347683 Free PMC article.

2

ASPP1 and ASPP2: common activators of p53 family members.

Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T, Lu X. Bergamaschi D, et al. Mol Cell Biol. 2004 Feb;24(3):1341-50. doi: 10.1128/MCB.24.3.1341-1350.2004. Mol Cell Biol. 2004. PMID: 14729977 Free PMC article.

3

Inhibitory member of the apoptosis-stimulating proteins of the p53 family (iASPP) interacts with protein phosphatase 1 via a noncanonical binding motif.

Llanos S, Royer C, Lu M, Bergamaschi D, Lee WH, Lu X. Llanos S, et al. Among authors: bergamaschi d. J Biol Chem. 2011 Dec 16;286(50):43039-44. doi: 10.1074/jbc.M111.270751. Epub 2011 Oct 13. J Biol Chem. 2011. PMID: 21998301 Free PMC article.

4

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X, Crook T. Bergamaschi D, et al. Cancer Cell. 2003 Apr;3(4):387-402. doi: 10.1016/s1535-6108(03)00079-5. Cancer Cell. 2003. PMID: 12726864 Free article.

5

Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo.

Zhang W, Bergamaschi D, Jin B, Lu X. Zhang W, et al. Among authors: bergamaschi d. Blood. 2005 May 1;105(9):3691-8. doi: 10.1182/blood-2003-07-2558. Epub 2005 Jan 21. Blood. 2005. PMID: 15665120 Free article.

6

Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.

Bergamaschi D, Samuels Y, Zhong S, Lu X. Bergamaschi D, et al. Oncogene. 2005 May 26;24(23):3836-41. doi: 10.1038/sj.onc.1208535. Oncogene. 2005. PMID: 15782125

7

ASPP proteins specifically stimulate the apoptotic function of p53.

Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T, Lu X. Samuels-Lev Y, et al. Among authors: bergamaschi d. Mol Cell. 2001 Oct;8(4):781-94. doi: 10.1016/s1097-2765(01)00367-7. Mol Cell. 2001. PMID: 11684014 Free article.

8

Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.

Sullivan A, Syed N, Gasco M, Bergamaschi D, Trigiante G, Attard M, Hiller L, Farrell PJ, Smith P, Lu X, Crook T. Sullivan A, et al. Among authors: bergamaschi d. Oncogene. 2004 Apr 22;23(19):3328-37. doi: 10.1038/sj.onc.1207428. Oncogene. 2004. PMID: 15077186

9

A new inhibitor of apoptosis from vaccinia virus and eukaryotes.

Gubser C, Bergamaschi D, Hollinshead M, Lu X, van Kuppeveld FJ, Smith GL. Gubser C, et al. Among authors: bergamaschi d. PLoS Pathog. 2007 Feb;3(2):e17. doi: 10.1371/journal.ppat.0030017. PLoS Pathog. 2007. PMID: 17319741 Free PMC article.

10

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.

Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A, Del Sal G, Syed N, Smith P, Gasco M, Crook T, Lu X. Bergamaschi D, et al. Nat Genet. 2006 Oct;38(10):1133-41. doi: 10.1038/ng1879. Epub 2006 Sep 10. Nat Genet. 2006. PMID: 16964264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters